PRPH Projected Dividend Yield
ProPhase Labs Inc ( NASDAQ : PRPH )ProPhase Labs, Inc. is a biopharma, genomics, and diagnostics company. Co. provides whole genome sequencing solutions, while developing potential diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. Its segments include diagnostic services and consumer products. The diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the U.S., including health plans, third party payers and government organizations. 16 YEAR PERFORMANCE RESULTS |
PRPH Dividend History Detail PRPH Dividend News PRPH Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
2022 |
May 13, 2022 |
May 24, 2022 |
May 25, 2022 |
Jun 03, 2022 |
0.3000 |
2022 |
Feb 16, 2022 |
Feb 28, 2022 |
Mar 01, 2022 |
Mar 10, 2022 |
0.3000 |
2022 Total: |
0.6000 |
||||
2021 |
May 13, 2021 |
May 24, 2021 |
May 25, 2021 |
Jun 03, 2021 |
0.3000 |
2021 Total: |
0.3000 |
||||
2019 |
Nov 20, 2019 |
Dec 02, 2019 |
Dec 03, 2019 |
Dec 12, 2019 |
0.2500 |
2019 |
Dec 26, 2018 |
Jan 09, 2019 |
Jan 10, 2019 |
Jan 24, 2019 |
0.2500 |
2019 Total: |
0.5000 |